Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes.
about
Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic controlIndicators of "healthy aging" in older women (65-69 years of age). A data-mining approach based on prediction of long-term survivalAssociation of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variationTelomere length in prospective and retrospective cancer case-control studiesLeukocyte telomere length and diabetes status, duration, and control: the 1999-2002 National Health and Nutrition Examination Survey.Global Gene Expression Profiling in Omental Adipose Tissue of Morbidly Obese Diabetic African AmericansTelomere length and pancreatic cancer: a case-control study.Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine.Using biomarkers of aging to identify modifiable mechanisms underlying age-related risk for cancer.The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?Accelerated telomere shortening in rheumatic diseases: cause or consequence?The influence of the telomere-telomerase system on diabetes mellitus and its vascular complications.Losartan inhibits STAT1 activation and protects human glomerular mesangial cells from angiotensin II induced premature senescence.Telomere length in atherosclerosis and diabetes.Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study.Comparison of telomere length measurement methods.STAT1 mediates cellular senescence induced by angiotensin II and H₂O₂ in human glomerular mesangial cells.Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus
P2860
Q33375213-45E2738B-454D-4868-8C65-76C7DCDDD334Q33661044-2025B053-6E52-4D64-8D71-6D4E15CC6C0AQ33729788-F7C88210-55A2-496B-B50A-E4DCFB70FFC2Q33794700-257305C6-AE90-429F-B268-9C48F9A7F57BQ35792209-31EE9581-DBA7-4806-AD83-394485ED6A57Q36201638-18D8B304-34E8-4291-A87A-F1464FD0D061Q36385369-9BD24437-E317-4C33-9C3C-848BC84C3744Q36772839-130BA7AB-ACA6-48A7-ACAB-7689304476BAQ37418643-7C60862E-0FAC-4566-BA51-25F97EF2DD5CQ38103313-27687B06-958D-4912-AE0B-DDC05BEF597FQ38161558-3B513501-7579-44F5-A5E1-B4D2F31A511CQ38353839-1EFA8C2B-DD0C-4460-91D2-2623EB624991Q39417862-A395E557-D932-43AC-AF62-76E7091E61D6Q40286487-A739DF4F-EE00-4FF5-9CA0-C4A261C705D2Q40695544-35F1C134-C03C-483A-9AAD-42BEEF3C26EDQ42150413-8D60FEDC-778F-4B0E-9048-8A64FB3362E1Q52715473-3BCE4E34-BD07-42F4-AF4D-F7127D9ECFA3Q54541213-F981D832-B4BB-4BEC-8936-0B5534A9E8A3Q58829026-7439C9CE-0DC8-47AC-BFBC-5D384DD9D211
P2860
Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Chromosomal telomere attrition ...... phenotypes in type 2 diabetes.
@ast
Chromosomal telomere attrition ...... phenotypes in type 2 diabetes.
@en
type
label
Chromosomal telomere attrition ...... phenotypes in type 2 diabetes.
@ast
Chromosomal telomere attrition ...... phenotypes in type 2 diabetes.
@en
prefLabel
Chromosomal telomere attrition ...... phenotypes in type 2 diabetes.
@ast
Chromosomal telomere attrition ...... phenotypes in type 2 diabetes.
@en
P1433
P1476
Chromosomal telomere attrition ...... phenotypes in type 2 diabetes.
@en
P2093
P2888
P304
P356
10.1007/S00125-006-0322-4
P577
2006-06-21T00:00:00Z